Oct 2, 2025 07:10AM AngioDynamics (ANGO) Tops Q1 EPS by 2c, Offers Guidance

Jul 23, 2025 08:30AM AngioDynamics publishes PRESERVE study results in European Urology

Jul 17, 2025 06:49AM H.C. Wainwright Reiterates Buy Rating on AngioDynamics (ANGO)

Jul 16, 2025 08:39AM Lake Street Capital Markets Starts AngioDynamics (ANGO) at Buy

Jul 16, 2025 07:56AM AngioDynamics (ANGO) PT Raised to $17 at Canaccord Genuity

Jul 15, 2025 06:33AM AngioDynamics (ANGO) Tops Q4 EPS by 9c, provides guidance

Apr 14, 2025 06:25AM Canaccord Genuity Reiterates Buy Rating on AngioDynamics (ANGO)

Apr 7, 2025 06:39AM AngioDynamics (ANGO) PT Raised to $16 at H.C. Wainwright

Apr 3, 2025 06:18AM Canaccord Genuity Reiterates Buy Rating on AngioDynamics (ANGO)

Apr 2, 2025 06:33AM AngioDynamics (ANGO) Tops Q3 EPS by 14c ; Offers Guidance

Jan 30, 2025 07:30AM AngioDynamics (ANGO) Initiates AMBITION BTK RCT and Registry to Advance Treatment for Critical Limb Ischemia

Jan 13, 2025 08:15AM AngioDynamics (ANGO) Announces Publication of APEX-AV Trial Results in JSCAI

Jan 8, 2025 06:32AM AngioDynamics (ANGO) Tops Q2 EPS by 7c; updates guidance

Dec 9, 2024 06:57AM AngioDynamics (ANGO) Receives FDA Clearance for The NanoKnife System for Prostate Tissue Ablation

Oct 21, 2024 08:05AM AngioDynamics (ANGO) Announces American Medical Association’s CPT Editorial Panel Grants Category I CPT for Irreversible Electroporation (IRE) in Prostate and Liver

Oct 7, 2024 06:35AM H.C. Wainwright Reiterates Buy Rating on AngioDynamics (ANGO)

Oct 4, 2024 12:15PM Oppenheimer Reiterates Outperform Rating on AngioDynamics (ANGO)

Oct 4, 2024 06:10AM AngioDynamics (ANGO) PT Lowered to $12 at Canaccord Genuity

Oct 3, 2024 06:32AM AngioDynamics (ANGO) Tops Q1 EPS by 5c ; Offers Guidance

Sep 20, 2024 06:50AM H.C. Wainwright Reiterates Buy Rating on AngioDynamics (ANGO)

Sep 19, 2024 04:46PM AngioDynamics (ANGO) Initiates RECOVER-AV Clinical Trial Assessing AlphaVac F18⁸⁵ System in Treatment of Pulmonary Embolism and Long-Term Functional Outcomes

Jul 17, 2024 06:50AM AngioDynamics (ANGO) PT Lowered to $13 at Canaccord Genuity

Jul 16, 2024 03:27PM AngioDynamics (ANGO) PT Raised to $13 at Oppenheimer

Jul 16, 2024 06:33AM AngioDynamics (ANGO) Tops Q4 EPS by 11c, provides guidance